摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-<5-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>-1H-tetrazol-1-yl>acetate | 141463-29-8

中文名称
——
中文别名
——
英文名称
ethyl 2-<5-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>-1H-tetrazol-1-yl>acetate
英文别名
ethyl 2-[5-[(2R,3S)-4-cyclohexyl-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]butyl]sulfanyltetrazol-1-yl]acetate
ethyl 2-<5-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>-1H-tetrazol-1-yl>acetate化学式
CAS
141463-29-8
化学式
C20H35N5O5S
mdl
——
分子量
457.594
InChiKey
ONCJREAGDLYPSO-HOTGVXAUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.55
  • 重原子数:
    31.0
  • 可旋转键数:
    10.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    128.46
  • 氢给体数:
    2.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    描述:
    ethyl 2-<5-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>-1H-tetrazol-1-yl>acetate盐酸 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 4.5h, 生成 4-{(S)-2-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-2-[(1S,2R)-1-cyclohexylmethyl-3-(1-ethoxycarbonylmethyl-1H-tetrazol-5-ylsulfanyl)-2-hydroxy-propylcarbamoyl]-ethyl}-imidazole-1-carboxylic acid tert-butyl ester
    参考文献:
    名称:
    Renin inhibitors containing C-termini derived from mercaptoheterocycles
    摘要:
    A series of transition-state analogues having heterocyclylthio C-termini has been synthesized and evaluated for inhibition of human renin. Addition of mercaptoheterocycles to a chiral Boc-amino epoxide intermediate led, after several steps, to the target [(2R,3S)-3-(BocPheHis-amino)-4-cyclohexyl-2-hydroxy-1-butyl]thio derivatives. Oxidation of the thioether to sulfone was also investigated. Several of the compounds, especially those derived from N1-substituted-5-mercaptotetrazoles or N4-substituted-3-mercapto-5-(trifluoromethyl)-1,2,4-triazoles, were moderately potent inhibitors of human plasma renin, having IC50 values of 30-40 nM. When selected compounds were administered intravenously to sodium-deficient rhesus monkeys at 0.3-1.2 mg/kg, they reduced plasma renin activity by 75-98%. However, this inhibition and the accompanying drop in blood pressure were of short duration.
    DOI:
    10.1021/jm00089a023
  • 作为产物:
    描述:
    ethyl 2-(5-mercapto-1H-tetrazol-1-yl)acetate(2R,3S)-3-(t-butoxycarbonylamino)-4-cyclohexyl-1,2-epoxybutaneN-甲基吗啉 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以83%的产率得到ethyl 2-<5-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>-1H-tetrazol-1-yl>acetate
    参考文献:
    名称:
    Renin inhibitors containing C-termini derived from mercaptoheterocycles
    摘要:
    A series of transition-state analogues having heterocyclylthio C-termini has been synthesized and evaluated for inhibition of human renin. Addition of mercaptoheterocycles to a chiral Boc-amino epoxide intermediate led, after several steps, to the target [(2R,3S)-3-(BocPheHis-amino)-4-cyclohexyl-2-hydroxy-1-butyl]thio derivatives. Oxidation of the thioether to sulfone was also investigated. Several of the compounds, especially those derived from N1-substituted-5-mercaptotetrazoles or N4-substituted-3-mercapto-5-(trifluoromethyl)-1,2,4-triazoles, were moderately potent inhibitors of human plasma renin, having IC50 values of 30-40 nM. When selected compounds were administered intravenously to sodium-deficient rhesus monkeys at 0.3-1.2 mg/kg, they reduced plasma renin activity by 75-98%. However, this inhibition and the accompanying drop in blood pressure were of short duration.
    DOI:
    10.1021/jm00089a023
点击查看最新优质反应信息